Cash RunwayThe company’s current cash runway is to the end of May 2025 and is actively exploring other financing solutions to extend its cash runway.
Clinical Trials RiskRisks include failure of TAH in clinical trials, which could impact future developments.
Regulatory And Market RisksRisks include failure to secure regulatory approval and failure to achieve commercial success due to market size, penetration rate, and competition.